We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

53 hedge funds and large institutions have $4.48M invested in Bionano Genomics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $166K | Put options by funds: $60K

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0.01% more ownership

Funds ownership: 0.15% → 0.16% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

4% less funds holding

Funds holding: 55 → 53 (-2)

20% less capital invested

Capital invested by funds: $5.61M → $4.48M (-$1.13M)

Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
11
Reduced
11
Closed
14
Calls
$166K
Puts
$60K
Net Calls
+$106K
Net Calls Change
-$906K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.54M
2
GC
GMT Capital
Georgia
+$486K
3
BlackRock
BlackRock
New York
+$204K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$181K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$179K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$610K
2
Citadel Advisors
Citadel Advisors
Florida
-$220K
3
XT
XTX Topco
Cayman Islands
-$108K
4
Jane Street
Jane Street
New York
-$100K
5
QC
Quadrature Capital
United Kingdom
-$97.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
DIM
26
DLK Investment Management
California
$8.37K – – –
Osaic Holdings
27
Osaic Holdings
Arizona
$7.66K -$44.7K -814 -81%
GS
28
GTS Securities
New York
$7.47K +$10.1K +184 New
Millennium Management
29
Millennium Management
New York
$7.22K +$9.73K +177 New
Citigroup
30
Citigroup
New York
$4.76K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$2.6K +$2.8K +51 +392%
FDCDDQ
32
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.98K -$275 -5 -9%
Credit Agricole
33
Credit Agricole
France
$1.8K – – –
Fidelity Investments
34
Fidelity Investments
Massachusetts
$1.77K -$605 -11 -20%
SPIA
35
Steward Partners Investment Advisory
New York
$1.36K +$1.81K +33 New
Wells Fargo
36
Wells Fargo
California
$926 -$275 -5 -18%
CFGS
37
Concourse Financial Group Securities
Alabama
$881 – – –
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$832 – – –
PCMC
39
Planning Capital Management Corporation
Pennsylvania
$685 +$934 +17 New
Bank of America
40
Bank of America
North Carolina
$624 -$824 -15 -50%
TWC
41
TD Waterhouse Canada
Ontario, Canada
$308 +$440 +8 New
GI
42
Gradient Investments
Minnesota
$203 +$275 +5 New
AWM
43
AllSquare Wealth Management
New York
$136 – – –
Barclays
44
Barclays
United Kingdom
$136 – – –
AWM
45
Activest Wealth Management
Florida
$136 +$165 +3 New
WIA
46
Wetzel Investment Advisors
Indiana
$111 – – –
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$86 – – –
AF
48
Aviso Financial
Ontario, Canada
$83 +$110 +2 New
Northwestern Mutual Wealth Management
49
Northwestern Mutual Wealth Management
Wisconsin
$74 – – –
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$58 -$55 -1 -50%
1
2
3

BNGO Hedge Fund Activity: Q2 2024 in Review

53 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2024, worth a combined $4.48M — down 20% from $5.61M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new BNGO positions and 14 closed out — a net gain of 1 holder — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.54M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $610K sold.

  • 53 institutional investors held Bionano Genomics (BNGO) as of Q2 2024, down from 55 in Q1 2024.
  • Funds reported $4.48M of Bionano Genomics stock for Q2 2024, down 20% quarter-over-quarter.
  • 15 funds opened new Bionano Genomics positions in Q2 2024 and 14 closed out, a net change of +1 holder.
  • The largest Bionano Genomics buyer in Q2 2024 was Armistice Capital, an estimated $1.54M added.
  • The largest Bionano Genomics seller in Q2 2024 was GSA Capital Partners, an estimated $610K sold.

Based on aggregated 13F filings for Q2 2024.